Abel Ekiri

Dr Abel B. Ekiri


Lecturer in Infectious Disease Epidemiology
BVM, MS, PhD, DACVPM
+44 (0)1483 688779
01 VSM 02

Biography

Areas of specialism

Infectious disease epidemiology; One Health; Hospital-acquired infections and infection prevention and control practices; Antimicrobial use practices and antimicrobial stewardship

University roles and responsibilities

  • Lecturer in Infectious Disease Epidemiology

    Research

    Research interests

    My teaching

    My publications

    Publications

    Usman O. Adekanye, Abel Bulamu Ekiri, Erika Galipo, Abubakar Bala Muhammad, Ana Mateus, Roberto M. La Ragione (2020)Knowledge, Attitudes and Practices of Veterinarians Towards Antimicrobial Resistance and Stewardship in Nigeria, In: Antibiotics MDPI

    Antimicrobial resistance (AMR) is a global health concern and the inappropriate use of antibiotics in animals and humans are considered contributing factors. A cross-sectional survey to assess the knowledge, attitudes and practices of veterinarians regarding AMR and antimicrobial stewardship was conducted in Nigeria. A total of 241 respondents completed an online survey. Only 21% of respondents correctly defined the term antimicrobial stewardship and 59.8% were unaware of the guidelines provided by the Nigeria AMR National Action Plan. Over half (51%) of respondents indicated that prophylactic antibiotic use was appropriate when farm biosecurity was poor. Only 20% of the respondents conducted antimicrobial susceptibility testing (AST) frequently, and the unavailability of veterinary laboratory services (82%) and the owner’s inability to pay (72%) were reported as key barriers to conducting AST. The study findings suggest a focus on the following areas of potential intervention may be useful in improving appropriate antibiotic use and antimicrobial stewardship among veterinarians in Nigeria: increased awareness of responsible antimicrobial use among practicing and new graduated veterinarians, increased dissemination of 33 regularly updated antibiotic use guidelines, increased understanding of the role of good biosecurity 34 and vaccination practices in disease prevention, and increased provision of AST at affordable costs.